-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
January 01, 2020 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Along with access to relatively inexpensive illicit opioid drugs, such as heroin, and
increased use … Available:
http://www.accessdata.fda.gov/scripts/cder/drugs
atfda/index.cfm? … For drugs that save lives, a steep
cost. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
January 01, 2016 - San Diego (CA): Amylin
Pharmaceuticals, Inc.; 2010 Jun 15 [accessed
2011 Feb 22]. [3 p]. … Amylin Pharmaceuticals. … San Diego (CA): Amylin
Pharmaceuticals, Inc.; 2012 Jan 27 [accessed
2012 Feb 20]. [4 p]. … San
Diego (CA): Amylin Pharmaceuticals, Inc.; 2012
Jan 27. 11 p. … Get drugs straight to the eye.
[internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
January 27, 2012 - The following designs were also eligible for KQ 3 if they
compared two or more drugs of interest: nonrandomized … cohort studies,
and case-control studies were eligible as long as the
studies compared two or more drugs … J Stud Alcohol Drugs. 2008 Jul;69(4):535-8.
PMID: 18612569.
19. … J Stud Alcohol Drugs. 2009 Mar;70(2):186-96.
PMID: 19261230.
47. … Chronic care management for
dependence on alcohol and other drugs: the AHEAD randomized
trial.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0075_03-10-2009.pdf
January 01, 2009 - corticosteroids, immune system suppressors,
antibiotics, anti-diarrheals, anti-tumor necrosis factor (TNF) drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0313_02-09-2009.pdf
January 01, 2009 - A number of drugs and dietary measures have been shown to reduce the rate of stone
recurrence.
-
effectivehealthcare.ahrq.gov/sites/default/files/s16.pdf
October 01, 2007 - controlled trials (RCTs) remain the ac-
cepted “gold standard” for determining the efficacy of new drugs … Follow-up and monitoring is
designed to promote adherence to the drugs under study and
to detect any … Drug coverage—Which bisphosphonate drugs should be included on a
drug fomulary? … , quality of intervention
Timing of intervention
Cointerventions, quality of care
Adherence (for drugs … Treatment with drugs to lower
blood pressure and blood cholesterol based on an individual’s absolute
-
effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
October 01, 2007 - Rapid Cycle
Analysis Team
Background: Rare but serious adverse events associated with vac-
cines or drugs … meningococcal vaccine, drug safety
(Med Care 2007;45: S89–S95)
Concerns about the safety of vaccines and drugs … the
Centers for Disease Control and Prevention (CDC) and Food
and Drug Administration (FDA) and, for drugs … In addition, because drugs treat specific conditions, the pool
of users for a new medication is limited … early detection of potential adverse events after the
introduction of new vaccines, and possibly new drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_research-protocol.pdf
December 06, 2010 - Available therapies for RA include
corticosteroids, oral disease-modifying antirheumatic drugs (DMARDs … Finally, very little is known about the
benefits or risks of these drugs AMONG different patient subgroups … review did not include certolizumab pegol, golimumab,
and tocilizumab (listed above), because these drugs … Golimumab Simponi®
Tocililizumab Actemra®, RoActemrai®
• Comparators:
For all KQs: all review drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
August 01, 2017 - Food and Drug Administration (FDA) has
approved several prescription drugs for insomnia, typically … Food and Drug Administration
(FDA) for insomnia.
d Other benzodiazepines include drugs approved by … the FDA for insomnia (estazolam, flurazepam, lorazepam, quazepam, and triazolam) and drugs
not approved
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
May 01, 2006 - trials
comparing darbepoetin to epoetin showed no
statistically significant difference between these
drugs … trials comparing
darbepoetin to epoetin showed no statistically
significant difference between these drugs … trials comparing
darbepoetin to epoetin showed no statistically
significant difference between these drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
January 27, 2012 - prevention or pharmacotherapy combined with
various co-interventions (including both FDA-approved drugs … Inpatient settings
Interventions As defined above in PICOTS Pharmacotherapy for alcohol
withdrawal; any drugs … J Stud Alcohol Drugs.
2008 Jul;69(4):535-8. PMID: 18612569.
23.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
January 09, 2020 - However, simple analgesics including
2
nonsteroidal anti-inflammatory drugs (NSAIDs) used … reason, the American Headache Society has explicitly stated
that opioids and butalbital-containing drugs … therapy versus: 1) nonopioid
pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs … effectiveness of nonopioid pharmacologic therapy (e.g.,
acetaminophen, nonsteroidal anti-inflammatory drugs … , topical nonopioid abortive
drug, including:
• Acetaminophen
• Nonsteroidal anti-inflammatory drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Results
The table below lists the four topics for which (1) preliminary phase III data for drugs, at … San Diego (CA): Amylin
Pharmaceuticals, Inc.; 2012 Jan 27 [accessed
2014 Apr 10]. [5 p]. … Get drugs straight to the eye.
[internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0108_05-24-2009.pdf
January 01, 2009 - migraine patients require multiple
doses and often do not relieve the migraine and that some other drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-199-skin-cancer.pdf
December 01, 2017 - • Recurrence rates for SCC in
situ were lower with PDT and
cryotherapy than with drugs. … Adverse Events, All BCC Lesions
In Table B drugs were most likely to have adverse events
leading to … Conversely, use of topical drugs is
generally limited to primary, superficial tumors. … Therefore,
comparisons of the efficacy of radiation and drugs for the
low-risk BCCs included in our … Adjuvant radiotherapy and new drugs (including epidermal
growth factor receptor inhibitors, such as
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
July 06, 2015 - Antihypertensive drugs and risk of cancer: network
meta-analyses and trial sequential analyses of 324 … The primary goal of this review is to identify any missing studies, drugs, interventions, or
devices … is needed to determine if ACE inhibitors or ARBs offer
additional benefits over other vasoactive drugs … Since ONTARGET
directly compared the same drugs as were evaluated in
the placebo-controlled HOPE and … Since ONTARGET
directly compared the same drugs as
were evaluated in the placebo-
controlled HOPE and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
January 01, 2007 - Both
drugs are produced by the same manufacturer,
which funded all available studies. … The second-
generation antidepressants cannot be considered
identical drugs. … Evidence of moderate strength supports
some differences among individual drugs with respect
to onset … The
incidence was 8-percent (95-percent CI, 3-11
percent) higher than with comparator drugs. … Mirtazapine led to higher weight gains than
comparator drugs (fluoxetine, paroxetine,
venlafaxine, and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - CER # 28:
Disease-Modifying Antirheumatic Drugs (DMARDs) in
Children with Juvenile Idiopathic Arthritis … ..................................................... 5
1
Disease-Modifying Antirheumatic Drugs … Introduction
Comparative Effectiveness Review (CER) #28, Disease-Modifying Antirheumatic Drugs … examples of how advances in understanding the biology of inflammation have led to
development of drugs … Disease-Modifying Antirheumatic Drugs
(DMARDs) in Children with Juvenile
Idiopathic Arthritis (JIA)
-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
November 01, 2008 - most regulatory approvals, and the source of most advertising and other claims made on
behalf of drugs … For example,
a systematic review of nonsteroidal anti-inflammatory drugs (NSAIDs) found cyclo-oxygenase … Do selective
cyclo-oxygenase-2 inhibitors and traditional
non-steroidal anti-inflammatory drugs … Gastrointestinal toxicity with celecoxib vs
nonsteroidal anti-inflammatory drugs for
osteoarthritis … Causality assessment
of adverse reactions to drugs—I.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - CER # 28:
Disease-Modifying Antirheumatic Drugs (DMARDs) in
Children with Juvenile Idiopathic Arthritis … ..................................................... 5
1
Disease-Modifying Antirheumatic Drugs … Introduction
Comparative Effectiveness Review (CER) #28, Disease-Modifying Antirheumatic Drugs … examples of how advances in understanding the biology of inflammation have led to
development of drugs … Disease-Modifying Antirheumatic Drugs
(DMARDs) in Children with Juvenile
Idiopathic Arthritis (JIA)